Health-care companies rose as investors rotated out of "growth" sectors like biotech stocks and into "value" sectors such as industrials. President Trump and his advisers have taken a more hands-on role than previously known in shaping Covid-19 recommendations from the Centers for Disease Control and Prevention, The Wall Street Journal reported. Shares of biotech Vertex Pharmaceuticals fell sharply after it halted a mid-stage trial of a treatment for a rare liver and lung disease, spurring worries that it would not be able to replicate success with a cystic-fibrosis treatment and diversify its revenue. Continue reading →

Stephanie Bowens | StarNews Correspondent When someone has dementia, or severe loss of memory and impairment in mental and behavioral abilities significant enough to interfere with daily function, it can dramatically impact the persons life and the lives of their loved ones. Dementia with Lewy Bodies, or DLB, is one of the most common causes of dementia and affects over a million people in the US. Dr Continue reading →

Earlier this year, health systems across the country suspended nearly all screening mammography due to COVID-19. Continue reading →

The latestrelease from Database of Data Bridge Market Research has recently published the Global research Report TitledParkinsons Disease Treatment Market. The study provides an overview of current statistics and future predictions of the Global Parkinsons Disease Treatment Market.The study highlights a detailed assessment of the Market and displays market sizing trends by revenue & volume (if applicable), current growth factors, expert opinions, facts, and industry-validated market development data. Global parkinsons disease market is anticipated to rise from its initial estimated value of USD 4.57 billion in 2018 to an estimated value of USD 7.57 billion by 2026, registering a CAGR of 6.5% in the forecast period of 2019-2026. Continue reading →